Correlation Between LARGAN Precision and Orient Europharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both LARGAN Precision and Orient Europharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LARGAN Precision and Orient Europharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between LARGAN Precision Co and Orient Europharma Co, you can compare the effects of market volatilities on LARGAN Precision and Orient Europharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LARGAN Precision with a short position of Orient Europharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of LARGAN Precision and Orient Europharma.

Diversification Opportunities for LARGAN Precision and Orient Europharma

-0.17
  Correlation Coefficient

Good diversification

The 3 months correlation between LARGAN and Orient is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding LARGAN Precision Co and Orient Europharma Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orient Europharma and LARGAN Precision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LARGAN Precision Co are associated (or correlated) with Orient Europharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orient Europharma has no effect on the direction of LARGAN Precision i.e., LARGAN Precision and Orient Europharma go up and down completely randomly.

Pair Corralation between LARGAN Precision and Orient Europharma

Assuming the 90 days trading horizon LARGAN Precision Co is expected to generate 0.5 times more return on investment than Orient Europharma. However, LARGAN Precision Co is 2.01 times less risky than Orient Europharma. It trades about 0.11 of its potential returns per unit of risk. Orient Europharma Co is currently generating about -0.01 per unit of risk. If you would invest  250,500  in LARGAN Precision Co on October 6, 2024 and sell it today you would earn a total of  8,000  from holding LARGAN Precision Co or generate 3.19% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

LARGAN Precision Co  vs.  Orient Europharma Co

 Performance 
       Timeline  
LARGAN Precision 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in LARGAN Precision Co are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, LARGAN Precision is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Orient Europharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Orient Europharma Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Orient Europharma is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

LARGAN Precision and Orient Europharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with LARGAN Precision and Orient Europharma

The main advantage of trading using opposite LARGAN Precision and Orient Europharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LARGAN Precision position performs unexpectedly, Orient Europharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orient Europharma will offset losses from the drop in Orient Europharma's long position.
The idea behind LARGAN Precision Co and Orient Europharma Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios